By John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT As 2026 begins, we are updating investors on Lantheus Holdings, Inc. (NASDAQ:LNTH), highlighting several recent developments.

Add Yahoo as a preferred source to see more of our stories on Google. Johns Hopkins researchers tie loss of the CSE enzyme to memory decline and Alzheimer’s-like brain damage in mice. (CREDIT: ...

Researchers at Johns Hopkins Medicine, led by Bindu Paul, an associate professor of pharmacology, psychiatry and neuroscience at the Johns Hopkins University School of Medicine, reported new evidence ...

Scientists may have pinpointed a way to reverse Alzheimer’s disease in an animal study. The study, led by University Hospitals Cleveland Medical Center, found that restoring a central cellular energy ...

With over 7 million people over 65 dealing with the degenerative disease — and the number expected to almost double by 2050 — Alzheimer’s is the most common form of dementia. But two new ...

Scientists studying Alzheimer’s in African Americans have uncovered a striking genetic clue that may cut across racial lines. In brain tissue from more than 200 donors, the gene ADAMTS2 was ...

There were breakthroughs in Alzheimer's disease and sleep apnea. From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer's disease, 2025 has been a year full ...